|
|
| |
| ORIGINAL ARTICLES |
| |
| The impact of clinical pharmacist in a cardiac-surgery intensive care unit |
| |
| Abdulrazaq S. Al-Jazairi, Amal A. Al-Agil, Yousif A. Asiri, Tariq A. Al-Kholi, Nathem S. Akhras, Bashar K. Horanieh
|
| |
| ABSTRACT |
| |
Objectives: To evaluate the clinical pharmacists’ interventions in an intensive care unit (ICU) setting with regard to their acceptance by the medical team, frequency, clinical significance, and targeted patient’s outcomes.
Methods: This is a prospective, non-comparative, observational study evaluating the clinical pharmacist
interventions in an ICU setting from December 2002 to May 2003. The study was conducted in a 19-bed Cardiac-Surgery ICU at King Faisal Specialist Hospital & Research Center, a tertiary-care hospital in Riyadh, Saudi Arabia. The clinical pharmacist performed daily multi-disciplinary team rounds, with documentation of all his interventions. On the same day, a physician, who is a part of the team, verified all interventions for validity and clinical significance. The institutional Office of Research Affairs approved the study.
Results: The clinical pharmacist intervened 394 times on the 600 patients [0.66 intervention-per-patient]. The medical team accepted almost all interventions (94.3%). The main drug-related problems were the following: no drug prescribed for medical condition (33.2%), inappropriate dosing regimen (28.9%), and no indication for drug use (14.3%). Approximately 55.7% of the interventions targeted enhancing therapeutic outcomes, whilst 21.8% of interventions resulted in the prevention of an adverse drug reaction. The interventions that may have resulted in decreasing mortality, preventing, or reducing organ damage, or decreasing hospitalization, represented 8.1% of all interventions.
Conclusions: Participation of a clinical pharmacist in the daily multidisciplinary team rounds in an ICU setting significantly reduces unfavorable morbidities and enhances therapeutic outcomes.
|
| |
| |
| Saudi Medical Journal 2008; Vol. 29 (2): 277-281 |
| |
|
| |
|
| From the Departments of Pharmacy Services (Al-Jazairi, Al-Agil, Akhras, Horanieh), Cardiovascular Disease, King Faisal Specialist Hospital & Research Center, and the Department of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Received 4th August 2007. Accepted 11th December 2007.
Address correspondence and reprint request to: Dr. Abdulrazaq S. Al-Jazairi, Assistant Head, Department of Pharmacy Services, King Faisal Specialist Hospital & Research Center, PO Box 3354, MBC-11, Riyadh 11211, Kingdom of Saudi Arabia. Tel. +966 (1) 4427603. Fax. +966 (1) 4427608. E-mail: ajazairi@kfshrc.edu.sa |
| |
|
|
|
|